|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 59.25 USD | +1.01% |
|
-2.20% | +25.77% |
| 07-15 | Bruker Acquires Noscendo's Disqver Clinical Metagenomics Platform | MT |
| 07-14 | Bruker Corporation acquired DISQVER Clinical Metagenomics Platform of Noscendo GmbH. | CI |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Bullish | Bullish |
| Resistance | 62.7 | 62.7 | 61.64 |
| Spread/Res. | -5.50% | -5.50% | -3.88% |
| Spread/Supp. | +9.26% | +39.12% | +38.18% |
| Support | 54.23 | 42.59 | 42.88 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- BRKR Stock
- Charts Bruker Corporation
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition